This sample business plan has been made available to users of Bplans.

com, published
by Palo Alto Software. Our sample plans were developed by existing companies and
new business start-ups as research instruments to determine market viability, or
funding availability. Names, locations and numbers may have been changed, and
substantial portions of text may have been omitted to preserve
confidentiality and proprietary information.

You are welcome to use this plan as a starting point to create your own, but you do not
have permission to reproduce, resell, publish, distribute
or even copy this plan as it exists here.

Requests for reprints, academic use, and other dissemination of this sample plan should
be emailed to the marketing department of Palo Alto Software at
[email protected].

Copyright Palo Alto Software, Inc., 2020 All rights reserved.

Legal Page

Confidentiality Agreement

The undersigned reader acknowledges that the information provided by

_________________________ in this business plan is confidential; therefore, reader agrees not to
disclose it without the express written permission of _________________________.

It is acknowledged by reader that information to be furnished in this business plan is in all respects
confidential in nature, other than information which is in the public domain through other means
and that any disclosure or use of same by reader, may cause serious harm or damage to
_________________________.

Upon request, this document is to be immediately returned to _________________________.

___________________
Signature

___________________
Name (typed or printed)

___________________
Date
 Table of Contents

This is a business plan. It does not imply an offering of securities.

1.0 Executive Summary.....................................................................................................................1

Chart: Highlights...........................................................................................................................2
2.0 Company Summary......................................................................................................................2
Table: Start-up..............................................................................................................................2
Chart: Start-up..............................................................................................................................3
Table: Start-up Funding.............................................................................................................4
2.1 Mission...........................................................................................................................................4
2.2 Strategy........................................................................................................................................4
2.2.1 Strategic Alliances............................................................................................................5
2.3 Risks...............................................................................................................................................5
3.0 Services.............................................................................................................................................5
3.1 Research and Development..................................................................................................5
3.2 Market Needs..............................................................................................................................5
4.0 Market Analysis Summary.........................................................................................................5
Chart: Market Analysis (Pie).....................................................................................................6
Table: Market Analysis................................................................................................................6
4.1 Market Description....................................................................................................................6
4.2 Market Size..................................................................................................................................6
4.3 Customers and Target Markets...........................................................................................7
5.0 Competitive Analysis....................................................................................................................7
5.1 Competitive Edge......................................................................................................................7
6.0 Strategy and Implementation Summary.............................................................................7
Table: Sales Forecast..................................................................................................................8
Chart: Sales Monthly...................................................................................................................8
Chart: Sales by Year....................................................................................................................9
6.1 Marketing Communications...................................................................................................9
7.0 Management Summary.............................................................................................................10
Table: Personnel..........................................................................................................................10
8.0 Financial Plan................................................................................................................................10
8.1 Important Assumptions........................................................................................................10
Table: General Assumptions...................................................................................................10
8.2 Break-even Analysis...............................................................................................................11
8.2 Break-even Analysis...............................................................................................................11
Chart: Break-even Analysis....................................................................................................11
Table: Break-even Analysis....................................................................................................11
8.3 Projected Profit and Loss.....................................................................................................12
8.3 Projected Profit and Loss.....................................................................................................12
Chart: Gross Margin Monthly.................................................................................................12
Chart: Gross Margin Yearly.....................................................................................................12
Table: Profit and Loss................................................................................................................13
Chart: Profit Monthly.................................................................................................................14
Chart: Profit Yearly.....................................................................................................................14
8.4 Projected Cash Flow...............................................................................................................15
Page
 Table of Contents

Chart: Cash...................................................................................................................................15
Table: Cash Flow.........................................................................................................................16
8.5 Projected Balance Sheet......................................................................................................17
8.5 Projected Balance Sheet......................................................................................................17
Table: Balance Sheet.................................................................................................................17
8.6 Business Ratios........................................................................................................................18
8.6 Business Ratios........................................................................................................................18
Table: Ratios.................................................................................................................................18
Table: Sales Forecast..........................................................................................................................1
Table: Personnel....................................................................................................................................2
Table: Personnel....................................................................................................................................2
Table: General Assumptions.............................................................................................................3
Table: General Assumptions.............................................................................................................3
Table: Profit and Loss..........................................................................................................................4
Table: Profit and Loss..........................................................................................................................4
Table: Cash Flow...................................................................................................................................5
Table: Cash Flow...................................................................................................................................5
Table: Balance Sheet...........................................................................................................................6
Table: Balance Sheet...........................................................................................................................6

Page
 The Medical Group

1.0 Executive Summary

The Medical Group (TMG) has been formed to offer management services to doctors in the
ever-changing healthcare environment. A unique market opportunity currently presents itself to
a few skilled individuals who have both the awareness of this opportunity, and the experience,
credibility, and know-how to access this previously-untapped, profitable segment of
government health programs.

TMG has identified and begun the numerous tasks necessary to organize these traditional
physicians into a management services organization which will enable doctors to:

 Retain their walk-in patients

 Double their current Medicare reimbursement for walk-in patients
 Obtain a contract with Medicare

TMG has been formed to provide services to doctors and provide managed care access via
these physicians to Medicare HMOs. The managed care industry, including payors, doctors, and
hospitals, have been unaware of the potential walk-in patient population.

There are no companies in the Southern Texas healthcare market capable of accessing the
walk-in market. The company has a significant competitive advantage over any future
competitors based upon two factors:

 The development of a proprietary database of physicians with large walk-in patient bases in
this region.
 The development of a medical group comprised of the leading physicians with the largest
walk-in patient bases; TMG has a 20-year management contract with this medical group.

The company projects start-up development costs which will fund an initial development period
of approximately 12 months, at this point, profitable operation is expected to be reached.

Page 1
 The Medical Group

Chart: Highlights

Highlights

$45,000,000

$40,000,000

$35,000,000

$30,000,000 Sales

$25,000,000 Gross Margin

$20,000,000 Net Profit

$15,000,000

$10,000,000

$5,000,000

$0
Year 1 Year 2 Year 3

2.0 Company Summary

TMG was founded in July 1999 in Irving, Texas as a management service organization. TMG is a
Texas Corporation, with principal offices located in Irving. 

Table: Start-up

Start-up

Requirements

Start-up Expenses
Legal $2,000
Stationery etc. $2,000
Sales Materials $10,000
Consultants $14,000
Insurance $1,000
Rent $2,000
Research and development $40,000
Expensed equipment $20,000
Other $4,000
Total Start-up Expenses $95,000

Start-up Assets
Cash Required $250,000
Other Current Assets $5,000
Long-term Assets $0
Total Assets $255,000

Total Requirements $350,000

Page 2
 The Medical Group

Chart: Start-up

Start-up

$320,000

$280,000

$240,000

$200,000

$160,000

$120,000

$80,000

$40,000

$0
Expenses Assets Investment Loans

Page 3
 The Medical Group

Table: Start-up Funding

Start-up Funding
Start-up Expenses to Fund $95,000
Start-up Assets to Fund $255,000
Total Funding Required $350,000

Assets
Non-cash Assets from Start-up $5,000
Cash Requirements from Start-up $250,000
Additional Cash Raised $0
Cash Balance on Starting Date $250,000
Total Assets $255,000

Liabilities and Capital

Liabilities
Current Borrowing $0
Long-term Liabilities $0
Accounts Payable (Outstanding Bills) $0
Other Current Liabilities (interest-free) $0
Total Liabilities $0

Capital

Planned Investment
Michael Johnson $50,000
Seed Financing $300,000
Other $0
Additional Investment Requirement $0
Total Planned Investment $350,000

Loss at Start-up (Start-up Expenses) ($95,000)

Total Capital $255,000

Total Capital and Liabilities $255,000

Total Funding $350,000

2.1 Mission

The mission of TMG is to provide a management structure that will allow physicians to
access more managed care revenue. 

2.2 Strategy

TMG's market strategy is to build on its core alliance with the leading group of doctors
in Denton County, using the company's expertise in the healthcare industry, along with its
unique knowledge of the walk-in market and its extensive experience with managed care
payors, regulation, and management. 

Page 4
 The Medical Group

2.2.1 Strategic Alliances

The company has developed a strategic alliance with medical centers. These alliances are
valuable to TMG because these Medicare systems will support development, and because they
can also provide, under contract, infrastructure services that will enable TMG to avoid costly
infrastructure start-up costs and delays as it moves into operations.

2.3 Risks

The only risk that TMG realistically faces in the marketplace is that of developmental delays,
which may extend the period before profitable operations are initiated. To mitigate this risk,
TMG has made several conservative assumptions in the development of its operational budget. 
Operational staff levels are directly related to membership enrollment of walk-in patients. Once
operational status is obtained, profits are ensured. 

3.0 Services

TMG has obtained start-up capital and initiated development activities toward completing a
physician network for access to Medicare managed care revenues. TMG believes that they are
currently two years ahead of the industry in knowledge and experience.

3.1 Research and Development

TMG, through three years of research, has developed a proprietary and exclusive listing of all
physicians in Texas and their walk-in patient volumes. This research and management tool has
allowed us to identify and approach several local physicians. It is because of this knowledge
that Mr. Johnson is able to obtain initial seed development capital from the hospital system. His
knowledge and expertise in this market, and his relationship with key physicians, has been
widely recognized by several hospital systems in Southern Texas over the past few years.

3.2 Market Needs

TMG plans to respond to market needs by expanding into additional counties in the near future.
In addition, as TMG operations unfold, the utilization of the Internet as a billing mechanism is
foreseen. TMG projects that, as a part of its contract for infrastructure services for its
development, it will provide Internet activity to its member physicians for cost reductions and
ease of operations.

4.0 Market Analysis Summary

In 1993, the Texas State Department of Health Services announced the beginning of a process
to convert approximately 75% of the over 5 million medical recipients in the state into a
healthcare environment. This artificial government interdiction into the healthcare delivery
system in Texas has had a significant impact on medical recipients, payors, and most
importantly, doctors.

This change, in combination with changes in the Medicare Act, has created an opportunity for
TMG to provide a managed care access vehicle to doctors for an extremely profitable portion of
the healthcare delivery system, individuals who have both Medicare and Medical health benefits
(walk-in).

Page 5
 The Medical Group

Chart: Market Analysis (Pie)

Market Analysis (Pie)

Walk-in Patients

Doctors

Other

Table: Market Analysis

Market Analysis
Year 1 Year 2 Year 3 Year 4 Year 5
Potential Customers Growth CAGR
Walk-in Patients 25% 200,000 250,000 312,500 390,625 488,281 25.00%
Doctors 15% 500 575 661 760 874 14.98%
Other 5% 150 158 166 174 183 5.10%
Total 24.97% 200,650 250,733 313,327 391,559 489,338 24.97%

4.1 Market Description

The managed care industry is a vital component of the healthcare delivery system of the United
States. Its component parts are payors (HMOs), physicians (managed care entities such as IPAs
and MSOs), hospitals, and other providers.

4.2 Market Size

In Denton County there are over 300,000 individuals with both Medicare and Medical coverage
(walk-in). In the five Southern Texas Counties (Denton, Garland, Dallas, Plano, and Memphis),
there are 330,000 walk-in, and in the whole state, there are 650,000 walk-in. In Denton, there
are 436,000 Medicare recipients. Currently 17% of those recipients are in Medicare HMOs and
approximately 592,000 are not. Of this 592,000, approximately one third (1/3) are walk-in. In
the State of Texas, there are 1.8 million Medicare recipients with 27.22% currently in HMOs.
That leaves 1.5 million Medicare members still not in HMO's. Walk-ins are one third (1/3) of
that total, or 650,000 eligible.  

Page 6
 The Medical Group

4.3 Customers and Target Markets

Doctors and the walk-in market

In Denton County there are approximately 1.8 million medical recipients, of whom, more
than 200,000 are walk-in patients, or individuals who have both Medical and Medicare. 

In Denton County alone there are over 330 physicians who fall into the category of doctors with
more than 100 walk-in patients in their practice base. This group, which incorporated in the
spring of 1999, has as its key officers physicians with walk-in patient levels in excess of 500. 

5.0 Competitive Analysis

Currently, TMG does not believe there are any competitive threats to its development and
penetration of the walk-in market in Southern Texas. That assessment is based upon the
following factors. 

5.1 Competitive Edge

TMG enjoys a significant competitive advantage over any entity who would attempt to
penetrate the walk-in market.

 Extensive customer list

 Qualified management team
 In-depth knowledge of the industry
 Solid business partnerships 

6.0 Strategy and Implementation Summary

The company plans to use the Internet as one of its primary marketing channels. The Internet
is a growing force in the buying and selling of a wide variety of products, including medical
services. According to International Data Corporation (IDC), a leading provider of information
technology data, aggregate Internet commerce across all industries was estimated to have
been $32 billion in 1998, and is projected to soar to $425 billion by 2002.

The Internet provides a relatively easy way to gather information and to shop for the best
deals, in terms of both price and needed attributes. Through websites, consumers can read a
variety of reviews to compare models and see which vehicles meet their needs. They can view,
search, and screen for prices, features, and other important information. For retailers, the
Internet is a means of increasing volume through leads that are converted into sales and a
means of decreasing marketing, advertising, and personnel costs per sale.

Page 7
 The Medical Group

11 12
10 Month
Table: Sales Forecast

9 Month
8 Month
7 Month
Sales Forecast
Year 1 Year 2 Year 3

6 Month
Sales

5 Month
Customers $250,000 $3,750,000 $10,750,000
Physician membership $325,000 $4,875,000 $15,875,000
Other services $500,000 $7,500,000 $18,500,000

4 Month
Total Sales $1,075,000 $16,125,000 $45,125,000

3 Month
Direct Cost of Sales Year 1 Year 2 Year 3

2 Month
Customers $33,330 $500,000 $1,102,564
Physician membership $0 $0 $0
Other services $66,670 $1,000,000 $1,897,436

1 Month
Subtotal Direct Cost of Sales $100,000 $1,500,000 $3,000,000

Chart: Sales Monthly MonthMonth

Sales Monthly

$100,000

$80,000
Customers

$60,000 Physician membership

Other services
$40,000

$20,000

$0

Page 8
 The Medical Group

Chart: Sales by Year

Sales by Year

$45,000,000

$40,000,000

$35,000,000
Customers
$30,000,000
Physician membership
$25,000,000

$20,000,000
Other services

$15,000,000

$10,000,000

$5,000,000

$0
Year 1 Year 2 Year 3

6.1 Marketing Communications

The key message associated with TMG's services are affordability and reliability for customers.
TMG believes that it can achieve success through the implementation of a new promotional
plan. The company's new promotional plan is diverse and includes a range of marketing:

 Print advertising. The company's print advertising program includes advertisements in the
Irving News Express and the military newspaper distributed by Prime Time News.
 Internet. TMG plans to develop a website through which it will generate sales beyond
Denton County. Plans are underway to develop a professional and effective site. In the
future, this is expected to be one of the company's primary marketing channels.
 Television and Radio. The company plans to expand its promotions into television
advertising. Currently, a number of local radio stations have been used for advertising
purposes. The company intends to use additional radio stations that have listener bases that
includes more of its target customers.
 Industry journals. The company plans on advertising in medical journals, local magazines
that dedicated to the medical industry.

Page 9
 The Medical Group

7.0 Management Summary

The company's management philosophy will be based on responsibility and mutual respect.
TMG will maintain an environment and structure that will encourage productivity and respect for
customers and fellow employees. Additionally, the environment will encourage employees to
have fun by allowing creative independence and providing challenges that are realistic and
rewarding.

TMG's management is highly experienced and qualified. Key members of TMG's management
teams, their backgrounds, and responsibilities are as follows.

Mr. Michael Johnson, President and CEO.

Note: Background has been removed for confidentiality.

Board of Advisors

It is TMG's intent to utilize the extensive contacts that Mr. Johnson has in the Southern Texas
market in terms of an Advisory Board to TMG and its owners. As TMG develops, depending
upon which hospital systems are utilized to the greatest amount, other healthcare delivery
executives will be invited to participate in the Board of Advisors.

Table: Personnel

Personnel Plan
Year 1 Year 2 Year 3
All Staff $256,522 $453,066 $608,696
Other $0 $0 $0
Total People 7 9 13

Total Payroll $256,522 $453,066 $608,696

8.0 Financial Plan

The company is raising funding to complete development through Year 2 of operation.  

8.1 Important Assumptions

The following table presents some assumptions that are necessary to the success of TMG.

Table: General Assumptions

General Assumptions
Year 1 Year 2 Year 3
Plan Month 1 2 3
Current Interest Rate 10.00% 10.00% 10.00%
Long-term Interest Rate 10.00% 10.00% 10.00%
Tax Rate 25.42% 25.00% 25.42%
Other 0 0 0

Page 10
 The Medical Group

8.2 Break-even Analysis

The chart and table below outline present the Break-even Analysis for TMG.

Chart: Break-even Analysis

Break-even Analysis
$40,000

$30,000

$20,000

$10,000

$0

($10,000)

($20,000)

($30,000)

($40,000)

($50,000)

($60,000)
$0 $20,000 $40,000 $60,000 $80,000 $100,000
$10,000 $30,000 $50,000 $70,000 $90,000 $110,000

Table: Break-even Analysis

Break-even Analysis

Monthly Revenue Break-even $69,700

Assumptions:
Average Percent Variable Cost 9%
Estimated Monthly Fixed Cost $63,217

Page 11
 The Medical Group

8.3 Projected Profit and Loss

The company is in the early stage of development, thus initial projections have only been made
on accounts that are believed to most drive the income statement. 

Chart: Gross Margin Monthly

Gross Margin Monthly

$100,000

$90,000

$80,000

$70,000

$60,000

$50,000

$40,000

$30,000

$20,000

$10,000

$0
Month 1 Month 3 Month 5 Month 7 Month 9 Month 11
Month 2 Month 4 Month 6 Month 8 Month 10 Month 12

Page 12
 The Medical Group

Chart: Gross Margin Yearly

Gross Margin Yearly

$40,000,000

$35,000,000

$30,000,000

$25,000,000

$20,000,000

$15,000,000

$10,000,000

$5,000,000

$0
Year 1 Year 2 Year 3

Table: Profit and Loss

Pro Forma Profit and Loss

Year 1 Year 2 Year 3
Sales $1,075,000 $16,125,000 $45,125,000
Direct Cost of Sales $100,000 $1,500,000 $3,000,000
Other $38,000 $570,000 $600,000
Total Cost of Sales $138,000 $2,070,000 $3,600,000

Gross Margin $937,000 $14,055,000 $41,525,000

Gross Margin % 87.16% 87.16% 92.02%

Expenses
Payroll $256,522 $453,066 $608,696
Sales and Marketing and Other Expenses $382,000 $2,163,810 $3,366,850
Depreciation $8,400 $0 $0
Continued education $36,000 $517,500 $575,500
Utilities $3,600 $4,000 $4,500
Insurance $9,600 $20,000 $25,000
Rent $24,000 $25,000 $25,000
Payroll Taxes $38,478 $67,960 $91,304
Other $0 $0 $0

Total Operating Expenses $758,600 $3,251,336 $4,696,850

Profit Before Interest and Taxes $178,400 $10,803,664 $36,828,150

EBITDA $186,800 $10,803,664 $36,828,150
Interest Expense $0 $0 $0
Taxes Incurred $42,564 $2,700,916 $9,360,488

Net Profit $135,835 $8,102,748 $27,467,662

Net Profit/Sales 12.64% 50.25% 60.87%

Page 13
 The Medical Group

Chart: Profit Monthly

Profit Monthly

$20,000

$15,000

$10,000

$5,000

$0

($5,000)

($10,000)

($15,000)

($20,000)

($25,000)

Month 1 Month 3 Month 5 Month 7 Month 9 Month 11

Month 2 Month 4 Month 6 Month 8 Month 10 Month 12

Chart: Profit Yearly

Profit Yearly

$30,000,000

$27,000,000

$24,000,000

$21,000,000

$18,000,000
$15,000,000

$12,000,000

$9,000,000

$6,000,000

$3,000,000

$0
Year 1 Year 2 Year 3

Page 14
 MonthMon
7
The Medical Group

MonthMonth
4 Month
5 6
8.4 Projected Cash Flow

Month 3
The cash flow projections are presented in the following chart and table.

MonthMonth
1 2
Chart: Cash

Cash

$500,000

$400,000

$300,000
Net Cash Flow

$200,000 Cash Balance

$100,000

$0

Page 15
 The Medical Group

Table: Cash Flow

Pro Forma Cash Flow

Year 1 Year 2 Year 3
Cash Received

Cash from Operations

Cash Sales $0 $0 $0
Cash from Receivables $868,500 $13,234,000 $39,554,302
Subtotal Cash from Operations $868,500 $13,234,000 $39,554,302

Additional Cash Received

Sales Tax, VAT, HST/GST Received $0 $0 $0
New Current Borrowing $0 $0 $0
New Other Liabilities (interest-free) $0 $0 $0
New Long-term Liabilities $0 $0 $0
Sales of Other Current Assets $0 $0 $0
Sales of Long-term Assets $0 $0 $0
New Investment Received $500,000 $0 $0
Subtotal Cash Received $1,368,500 $13,234,000 $39,554,302

Expenditures Year 1 Year 2 Year 3

Expenditures from Operations

Cash Spending $256,522 $453,066 $608,696
Bill Payments $616,643 $7,004,661 $16,269,509
Subtotal Spent on Operations $873,165 $7,457,727 $16,878,205

Additional Cash Spent

Sales Tax, VAT, HST/GST Paid Out $0 $0 $0
Principal Repayment of Current Borrowing $0 $0 $0
Other Liabilities Principal Repayment $0 $0 $0
Long-term Liabilities Principal Repayment $0 $0 $0
Purchase Other Current Assets $0 $0 $0
Purchase Long-term Assets $500,000 $2,000,000 $8,000,000
Dividends $0 $0 $0
Subtotal Cash Spent $1,373,165 $9,457,727 $24,878,205

Net Cash Flow ($4,665) $3,776,273 $14,676,097

Cash Balance $245,335 $4,021,608 $18,697,706

Page 16
 The Medical Group

8.5 Projected Balance Sheet

The table below provides TMG's projected balance sheet for 2000-2002. 

Table: Balance Sheet

Pro Forma Balance Sheet

Year 1 Year 2 Year 3
Assets

Current Assets
Cash $245,335 $4,021,608 $18,697,706
Accounts Receivable $206,500 $3,097,500 $8,668,198
Other Current Assets $5,000 $5,000 $5,000
Total Current Assets $456,835 $7,124,108 $27,370,903

Long-term Assets
Long-term Assets $500,000 $2,500,000 $10,500,000
Accumulated Depreciation $8,400 $8,400 $8,400
Total Long-term Assets $491,600 $2,491,600 $10,491,600
Total Assets $948,435 $9,615,708 $37,862,503

Liabilities and Capital Year 1 Year 2 Year 3

Current Liabilities
Accounts Payable $57,599 $622,125 $1,401,258
Current Borrowing $0 $0 $0
Other Current Liabilities $0 $0 $0
Subtotal Current Liabilities $57,599 $622,125 $1,401,258

Long-term Liabilities $0 $0 $0
Total Liabilities $57,599 $622,125 $1,401,258

Paid-in Capital $850,000 $850,000 $850,000

Retained Earnings ($95,000) $40,835 $8,143,584
Earnings $135,835 $8,102,748 $27,467,662
Total Capital $890,835 $8,993,584 $36,461,245
Total Liabilities and Capital $948,435 $9,615,708 $37,862,503

Net Worth $890,835 $8,993,584 $36,461,245

Page 17
 The Medical Group

8.6 Business Ratios

The following table contains important business ratios for the offices and clinics of medical
doctors industry, as determined by the Standard Industry Classification (SIC) Index code 8011,
Offices & Clinics of Medical Doctors.

Table: Ratios

Ratio Analysis
Year 1 Year 2 Year 3 Industry Profile
Sales Growth n.a. 1400.00% 179.84% 5.90%

Percent of Total Assets

Accounts Receivable 21.77% 32.21% 22.89% 10.00%
Other Current Assets 0.53% 0.05% 0.01% 50.50%
Total Current Assets 48.17% 74.09% 72.29% 60.80%
Long-term Assets 51.83% 25.91% 27.71% 39.20%
Total Assets 100.00% 100.00% 100.00% 100.00%

Current Liabilities 6.07% 6.47% 3.70% 39.80%

Long-term Liabilities 0.00% 0.00% 0.00% 14.10%
Total Liabilities 6.07% 6.47% 3.70% 53.90%
Net Worth 93.93% 93.53% 96.30% 46.10%

Percent of Sales
Sales 100.00% 100.00% 100.00% 100.00%
Gross Margin 87.16% 87.16% 92.02% 0.00%
Selling, General & Administrative Expenses 74.72% 36.91% 30.81% 57.10%
Advertising Expenses 6.14% 6.05% 2.77% 0.40%
Profit Before Interest and Taxes 16.60% 67.00% 81.61% 2.00%

Main Ratios
Current 7.93 11.45 19.53 1.37
Quick 7.93 11.45 19.53 1.12
Total Debt to Total Assets 6.07% 6.47% 3.70% 53.90%
Pre-tax Return on Net Worth 20.03% 120.13% 101.01% 6.90%
Pre-tax Return on Assets 18.81% 112.35% 97.27% 15.00%

Additional Ratios Year 1 Year 2 Year 3

Net Profit Margin 12.64% 50.25% 60.87% n.a
Return on Equity 15.25% 90.09% 75.33% n.a

Activity Ratios
Accounts Receivable Turnover 5.21 5.21 5.21 n.a
Collection Days 57 37 48 n.a
Accounts Payable Turnover 11.71 12.17 12.17 n.a
Payment Days 27 16 22 n.a
Total Asset Turnover 1.13 1.68 1.19 n.a

Debt Ratios
Debt to Net Worth 0.06 0.07 0.04 n.a
Current Liab. to Liab. 1.00 1.00 1.00 n.a

Liquidity Ratios
Net Working Capital $399,235 $6,501,984 $25,969,645 n.a
Interest Coverage 0.00 0.00 0.00 n.a

Additional Ratios
Assets to Sales 0.88 0.60 0.84 n.a
Current Debt/Total Assets 6% 6% 4% n.a
Acid Test 4.35 6.47 13.35 n.a

Page 18
 The Medical Group

Sales/Net Worth 1.21 1.79 1.24 n.a

Dividend Payout 0.00 0.00 0.00 n.a

Page 19
 Appendix

Table: Sales Forecast

Sales Forecast
Month 1 Month 2 Month 3 Month 4 Month 5 Month 6 Month 7 Month 8 Month 9 Month 10 Month 11 Month 12
Sales
Customers 0% $10,000 $10,000 $15,000 $15,000 $25,000 $25,000 $25,000 $25,000 $25,000 $25,000 $25,000 $25,000
Physician membership 0% $10,000 $15,000 $30,000 $30,000 $30,000 $30,000 $30,000 $30,000 $30,000 $30,000 $30,000 $30,000
Other services 0% $15,000 $20,000 $25,000 $40,000 $50,000 $50,000 $50,000 $50,000 $50,000 $50,000 $50,000 $50,000
Total Sales $35,000 $45,000 $70,000 $85,000 $105,000 $105,000 $105,000 $105,000 $105,000 $105,000 $105,000 $105,000

Direct Cost of Sales Month 1 Month 2 Month 3 Month 4 Month 5 Month 6 Month 7 Month 8 Month 9 Month 10 Month 11 Month 12
Customers $1,333 $1,333 $2,000 $2,000 $3,333 $3,333 $3,333 $3,333 $3,333 $3,333 $3,333 $3,333
Physician membership $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Other services $2,000 $2,667 $3,333 $5,334 $6,667 $6,667 $6,667 $6,667 $6,667 $6,667 $6,667 $6,667
Subtotal Direct Cost of Sales $3,333 $4,000 $5,333 $7,334 $10,000 $10,000 $10,000 $10,000 $10,000 $10,000 $10,000 $10,000

Page 1
 Appendix

Table: Personnel

Personnel Plan
Month 1 Month 2 Month 3 Month 4 Month 5 Month 6 Month 7 Month 8 Month 9 Month 10 Month 11 Month 12
All Staff 0% $21,375 $21,377 $21,377 $21,377 $21,377 $21,377 $21,377 $21,377 $21,377 $21,377 $21,377 $21,377
Other 0% $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Total People 7 7 7 7 7 7 7 7 7 7 7 7

Total Payroll $21,375 $21,377 $21,377 $21,377 $21,377 $21,377 $21,377 $21,377 $21,377 $21,377 $21,377 $21,377

Page 2
 Appendix

Table: General Assumptions

General Assumptions
Month 1 Month 2 Month 3 Month 4 Month 5 Month 6 Month 7 Month 8 Month 9 Month 10 Month 11 Month 12
Plan Month 1 2 3 4 5 6 7 8 9 10 11 12
Current Interest Rate 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00%
Long-term Interest Rate 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00%
Tax Rate 30.00% 25.00% 25.00% 25.00% 25.00% 25.00% 25.00% 25.00% 25.00% 25.00% 25.00% 25.00%
Other 0 0 0 0 0 0 0 0 0 0 0 0

Page 3
 Appendix

Table: Profit and Loss

Pro Forma Profit and Loss

Month 1 Month 2 Month 3 Month 4 Month 5 Month 6 Month 7 Month 8 Month 9 Month 10 Month 11 Month 12
Sales $35,000 $45,000 $70,000 $85,000 $105,000 $105,000 $105,000 $105,000 $105,000 $105,000 $105,000 $105,000
Direct Cost of Sales $3,333 $4,000 $5,333 $7,334 $10,000 $10,000 $10,000 $10,000 $10,000 $10,000 $10,000 $10,000
Other $2,500 $2,500 $2,500 $2,500 $3,500 $3,500 $3,500 $3,500 $3,500 $3,500 $3,500 $3,500
Total Cost of Sales $5,833 $6,500 $7,833 $9,834 $13,500 $13,500 $13,500 $13,500 $13,500 $13,500 $13,500 $13,500

Gross Margin $29,167 $38,500 $62,167 $75,166 $91,500 $91,500 $91,500 $91,500 $91,500 $91,500 $91,500 $91,500
Gross Margin % 83.33% 85.56% 88.81% 88.43% 87.14% 87.14% 87.14% 87.14% 87.14% 87.14% 87.14% 87.14%

Expenses
Payroll $21,375 $21,377 $21,377 $21,377 $21,377 $21,377 $21,377 $21,377 $21,377 $21,377 $21,377 $21,377
Sales and Marketing and Other $38,500 $31,000 $29,000 $36,500 $29,000 $29,000 $36,500 $29,000 $29,000 $36,500 $29,000 $29,000
Expenses
Depreciation $700 $700 $700 $700 $700 $700 $700 $700 $700 $700 $700 $700
Continued education $3,000 $3,000 $3,000 $3,000 $3,000 $3,000 $3,000 $3,000 $3,000 $3,000 $3,000 $3,000
Utilities $300 $300 $300 $300 $300 $300 $300 $300 $300 $300 $300 $300
Insurance $800 $800 $800 $800 $800 $800 $800 $800 $800 $800 $800 $800
Rent $2,000 $2,000 $2,000 $2,000 $2,000 $2,000 $2,000 $2,000 $2,000 $2,000 $2,000 $2,000
Payroll Taxes 15% $3,206 $3,207 $3,207 $3,207 $3,207 $3,207 $3,207 $3,207 $3,207 $3,207 $3,207 $3,207
Other $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0

Total Operating Expenses $69,881 $62,384 $60,384 $67,884 $60,384 $60,384 $67,884 $60,384 $60,384 $67,884 $60,384 $60,384

Profit Before Interest and Taxes ($40,714) ($23,884) $1,783 $7,282 $31,116 $31,116 $23,616 $31,116 $31,116 $23,616 $31,116 $31,116
EBITDA ($40,014) ($23,184) $2,483 $7,982 $31,816 $31,816 $24,316 $31,816 $31,816 $24,316 $31,816 $31,816
Interest Expense $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Taxes Incurred ($12,214) ($5,971) $446 $1,821 $7,779 $7,779 $5,904 $7,779 $7,779 $5,904 $7,779 $7,779

Net Profit ($28,500) ($17,913) $1,338 $5,462 $23,337 $23,337 $17,712 $23,337 $23,337 $17,712 $23,337 $23,337
Net Profit/Sales -81.43% -39.81% 1.91% 6.43% 22.23% 22.23% 16.87% 22.23% 22.23% 16.87% 22.23% 22.23%

Page 4
 Appendix

Table: Cash Flow

Pro Forma Cash Flow

Month 1 Month 2 Month 3 Month 4 Month 5 Month 6 Month 7 Month 8 Month 9 Month 10 Month 11 Month 12
Cash Received

Cash from Operations

Cash Sales $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Cash from Receivables $0 $1,167 $35,333 $45,833 $70,500 $85,667 $105,000 $105,000 $105,000 $105,000 $105,000 $105,000
Subtotal Cash from Operations $0 $1,167 $35,333 $45,833 $70,500 $85,667 $105,000 $105,000 $105,000 $105,000 $105,000 $105,000

Additional Cash Received

Sales Tax, VAT, HST/GST Received 0.00% $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
New Current Borrowing $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
New Other Liabilities (interest-free) $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
New Long-term Liabilities $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Sales of Other Current Assets $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Sales of Long-term Assets $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
New Investment Received $0 $0 $0 $500,000 $0 $0 $0 $0 $0 $0 $0 $0
Subtotal Cash Received $0 $1,167 $35,333 $545,833 $70,500 $85,667 $105,000 $105,000 $105,000 $105,000 $105,000 $105,000

Expenditures Month 1 Month 2 Month 3 Month 4 Month 5 Month 6 Month 7 Month 8 Month 9 Month 10 Month 11 Month 12

Expenditures from Operations

Cash Spending $21,375 $21,377 $21,377 $21,377 $21,377 $21,377 $21,377 $21,377 $21,377 $21,377 $21,377 $21,377
Bill Payments $1,381 $41,405 $41,027 $46,948 $57,532 $59,586 $59,773 $65,023 $59,586 $59,773 $65,023 $59,586
Subtotal Spent on Operations $22,756 $62,782 $62,404 $68,325 $78,909 $80,963 $81,150 $86,400 $80,963 $81,150 $86,400 $80,963

Additional Cash Spent

Sales Tax, VAT, HST/GST Paid Out $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Principal Repayment of Current Borrowing $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Other Liabilities Principal Repayment $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Long-term Liabilities Principal Repayment $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Purchase Other Current Assets $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Purchase Long-term Assets $25,000 $25,000 $25,000 $25,000 $50,000 $50,000 $50,000 $50,000 $50,000 $50,000 $50,000 $50,000
Dividends $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Subtotal Cash Spent $47,756 $87,782 $87,404 $93,325 $128,909 $130,963 $131,150 $136,400 $130,963 $131,150 $136,400 $130,963

Page 5
 Appendix
Net Cash Flow ($47,756) ($86,616) ($52,071) $452,508 ($58,409) ($45,296) ($26,150) ($31,400) ($25,963) ($26,150) ($31,400) ($25,963)
Cash Balance $202,244 $115,629 $63,558 $516,066 $457,657 $412,361 $386,211 $354,811 $328,848 $302,698 $271,298 $245,335

Table: Balance Sheet

Pro Forma Balance Sheet

Month 1 Month 2 Month 3 Month 4 Month 5 Month 6 Month 7 Month 8 Month 9 Month 10 Month 11 Month 12
Assets Starting Balances

Current Assets
Cash $250,000 $202,244 $115,629 $63,558 $516,066 $457,657 $412,361 $386,211 $354,811 $328,848 $302,698 $271,298 $245,335
Accounts Receivable $0 $35,000 $78,833 $113,500 $152,667 $187,167 $206,500 $206,500 $206,500 $206,500 $206,500 $206,500 $206,500
Other Current Assets $5,000 $5,000 $5,000 $5,000 $5,000 $5,000 $5,000 $5,000 $5,000 $5,000 $5,000 $5,000 $5,000
Total Current Assets $255,000 $242,244 $199,462 $182,058 $673,733 $649,824 $623,861 $597,711 $566,311 $540,348 $514,198 $482,798 $456,835

Long-term Assets
Long-term Assets $0 $25,000 $50,000 $75,000 $100,000 $150,000 $200,000 $250,000 $300,000 $350,000 $400,000 $450,000 $500,000
Accumulated Depreciation $0 $700 $1,400 $2,100 $2,800 $3,500 $4,200 $4,900 $5,600 $6,300 $7,000 $7,700 $8,400
Total Long-term Assets $0 $24,300 $48,600 $72,900 $97,200 $146,500 $195,800 $245,100 $294,400 $343,700 $393,000 $442,300 $491,600
Total Assets $255,000 $266,544 $248,062 $254,958 $770,933 $796,324 $819,661 $842,811 $860,711 $884,048 $907,198 $925,098 $948,435

Liabilities and Capital Month 1 Month 2 Month 3 Month 4 Month 5 Month 6 Month 7 Month 8 Month 9 Month 10 Month 11 Month 12

Current Liabilities
Accounts Payable $0 $40,044 $39,474 $45,033 $55,546 $57,599 $57,599 $63,037 $57,599 $57,599 $63,037 $57,599 $57,599
Current Borrowing $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Other Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Subtotal Current Liabilities $0 $40,044 $39,474 $45,033 $55,546 $57,599 $57,599 $63,037 $57,599 $57,599 $63,037 $57,599 $57,599

Long-term Liabilities $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $0 $40,044 $39,474 $45,033 $55,546 $57,599 $57,599 $63,037 $57,599 $57,599 $63,037 $57,599 $57,599

Paid-in Capital $350,000 $350,000 $350,000 $350,000 $850,000 $850,000 $850,000 $850,000 $850,000 $850,000 $850,000 $850,000 $850,000
Retained Earnings ($95,000) ($95,000) ($95,000) ($95,000) ($95,000) ($95,000) ($95,000) ($95,000) ($95,000) ($95,000) ($95,000) ($95,000) ($95,000)
Earnings $0 ($28,500) ($46,413) ($45,075) ($39,613) ($16,276) $7,061 $24,774 $48,111 $71,448 $89,161 $112,498 $135,835
Total Capital $255,000 $226,500 $208,587 $209,925 $715,387 $738,724 $762,061 $779,774 $803,111 $826,448 $844,161 $867,498 $890,835
Total Liabilities and Capital $255,000 $266,544 $248,062 $254,958 $770,933 $796,324 $819,661 $842,811 $860,711 $884,048 $907,198 $925,098 $948,435

Net Worth $255,000 $226,500 $208,587 $209,925 $715,387 $738,724 $762,061 $779,774 $803,111 $826,448 $844,161 $867,498 $890,835

Page 6
Appendix

Page 1